Back to Feed
ClinicalTrials.gov|Clinical Trial
PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Mesoblast, Inc.
Abstract
The objective of the present study is to establish the safety and efficacy of multiple administrations of Prochymal™(ex-vivo cultured human adult mesenchymal stem cells) in participants with moderate to severe chronic obstructive pulmonary disease (COPD). Phase: PHASE2 Status: COMPLETED Conditions: Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Chronic Bronchitis Interventions: Prochymal™; Placebo
Keywords
Pulmonary Disease, Chronic ObstructivePulmonary EmphysemaChronic Bronchitis